Copyright
©The Author(s) 2024.
World J Cardiol. Sep 26, 2024; 16(9): 512-521
Published online Sep 26, 2024. doi: 10.4330/wjc.v16.i9.512
Published online Sep 26, 2024. doi: 10.4330/wjc.v16.i9.512
Figure 1 Flowchart showing the inclusion data for the analysis.
Figure 2 Frequency of major adverse cardiac and cerebrovascular events in young (18-44 years) cannabis users (1152700) vs non-users (26323036).
Pearson’s χ² test and Kruskal Wallis test are used to analyze the categorical and continuous variables. CUD: Cannabis use disorder; MACCE: Major adverse cardiac and cerebrovascular events.
Figure 3 Trends in hospitalizations for major cardiovascular and cerebrovascular events among cannabis users vs.
non-users of age 18-44 years, excluding cases with concomitant substance abuse (Alcohol, tobacco, and cocaine) from 2016-2019. A: Trends in hospitalizations for major adverse cardiac and cerebrovascular events; B: Trends in hospitalizations for all-cause mortality; C: Trends in hospitalizations for acute myocardial infarction; D: Trends in hospitalizations for cardiac arrest; E: Trends in hospitalizations for stroke. CUD: Cannabis use disorder.
- Citation: Desai R, Gurram P, Mohammed AS, Salian RB, Lingamsetty SSP, Guntuku S, Medarametla RVSK, Jahan R, Muslehuddin Z, Ghantasala P. Contemporary nationwide trends in major adverse cardiovascular events in young cannabis users without concomitant tobacco, alcohol, cocaine use. World J Cardiol 2024; 16(9): 512-521
- URL: https://www.wjgnet.com/1949-8462/full/v16/i9/512.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i9.512